Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-19-000174

SVP, Commercial Operations gave up 2,395 shares (to pay taxes)

  • SVP, Commercial Operations acquired 7,318 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Adelman Michael SVP, Commercial Operations 2019-03-01 Option exercise +7,318 72,821 D
Adelman Michael SVP, Commercial Operations 2019-03-01 Shares withheld for taxes −2,395 $1.57 $3,760 70,426 D
Derivatives
Adelman Michael SVP, Commercial Operations 2019-02-28 Grant or award · Stock Option (right to buy) +67,400 67,400 D
Adelman Michael SVP, Commercial Operations 2019-03-01 Option exercise · Restricted Stock Unit −7,318 0 D
Loading xslF345X03/adelman.xml…